A self-administered cognitive test identified people who converted from mild cognitive impairment to dementia 6 months sooner than the Mini-Mental State Examination. (Alzheimer's Research & Therapy)
About half of people diagnosed with incident mild cognitive impairment were classified as cognitively normal at follow-up, a community-based cohort study showed. (Neurology)
Upper motor neuron loss in ALS appeared to occur independently of spinal motor neuron degeneration and may be an effective gene therapy target. (Gene Therapy)
Seizure patterns were identified in five of six patients who wore a wristwatch monitoring device and allowed about 30 minutes of warning before a seizure occurred. (Scientific Reports)
Both the format and the content of psychiatry training for neurology residents need to be revamped, two physicians argued. (JAMA Neurology)
Risk of more severe COVID-19 outcomes in MS patients receiving fingolimod (Gilenya) or siponimod (Mayzent) in postmarketing reports or clinical trials appeared to be similar to that of the overall MS population. (Neurology Neuroimmunology & Neuroinflammation)
A case of myasthenia gravis was linked to the Pfizer COVID-19 vaccine (Comirnaty). (Journal of Primary Care and Community Health)
Pandemic-related worries predicted deficits in cognition and altered risk perception. (PLOS One)
About one in 44 children were identified with autism spectrum disorder in 2018 in the CDC's Autism and Developmental Disabilities Monitoring (ADDM) Network; prevalence varied widely across the 11 ADDM sites. (Morbidity and Mortality Weekly Report)
Early approval pathways for drugs, like the one used to approve aducanumab (Aduhelm), often result in access accompanied by a persistent lack of evidence of benefit, health lawyers wrote in Science.
What can functional MRI tell us? The New Yorker looks at the science of reading thoughts.